Steven J. Romano

Sr. VP & Chief Scientific Ofcr, Keenova Therapeutics plc.

Companies

Silence Therapeutics plcEVP and Chief R&D Officer Jan 2, 2025 to now¹
Magenta TherapeuticsBoard member Sep 18, 2024 to now²
Keenova Therapeutics plcSr. VP & Chief Scientific Ofcr May 4, 2015 to Jun 21, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silence Therapeutics plc SLN12,993 shares⁴$121.2K at $9.32Jan 2, 2025
Keenova Therapeutics plc0 shares⁵Jun 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 16, 2022Returned to company 72,637 shares of Keenova Therapeutics plc⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSilence Therapeutics plc, EVP and Chief R&D Officer
2
SEC EDGARMagenta Therapeutics, Board member
3
SEC EDGARKeenova Therapeutics plc, Sr. VP & Chief Scientific Ofcr
4
SEC EDGARSilence Therapeutics plc shares after the filing of Jan 2, 2025
5
SEC EDGARKeenova Therapeutics plc shares after the filing of Jun 16, 2022